Market Overview

Research and Markets: Global Benign Prostatic Hyperplasia Drug Pipeline Capsule - 2012 Update

Share:
DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/gp6tkz/global_benign) has announced the addition of the "Global Benign Prostatic Hyperplasia Drug Pipeline Capsule - 2012 Update" report to their offering.

Fore Pharma's latest report 'Global Benign Prostatic Hyperplasia Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Benign Prostatic Hyperplasia market. It covers active Benign Prostatic Hyperplasia pipeline molecules in various stages of clinical trials, preclinical research, and drug discovery.

This report helps executives track competitors pipeline molecules. The information presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, executing in-licensing and out-licensing deals.

The report provides information on pipeline molecules by company and mechanism of action across the R&D stages. It also provides information on pipeline molecules developed in leading geographies (North America and Europe). Licensing activities are thoroughly captured in this report.

Key Features of the Report:

- Benign Prostatic Hyperplasia: Overview

- Benign Prostatic Hyperplasia Pipeline Overview

- Benign Prostatic Hyperplasia Phase 3 Clinical Trial Pipeline Insights

- Benign Prostatic Hyperplasia Phase 2 Clinical Trial Pipeline Insights

- Benign Prostatic Hyperplasia Phase 1 Clinical Trial Pipeline Insights

- Benign Prostatic Hyperplasia Preclinical Research Pipeline Insights

- Benign Prostatic Hyperplasia Discovery Stage Pipeline Insights

- Geographic Landscape of Benign Prostatic Hyperplasia R&D Activities

- Benign Prostatic Hyperplasia R&D Activities in North America

- Benign Prostatic Hyperplasia R&D Activities in Europe

- Licensing Activities / Partnerships

Key Topics Covered:

1. Benign Prostatic Hyperplasia - Disease Overview

2. Benign Prostatic Hyperplasia Pipeline Overview

3. Benign Prostatic Hyperplasia Phase 3 Clinical Trial Pipeline Insights

4. Benign Prostatic Hyperplasia Phase 2 Clinical Trial Pipeline Insights

5. Benign Prostatic Hyperplasia Phase 1 Clinical Trial Pipeline Insights

6. Benign Prostatic Hyperplasia Preclinical Research Pipeline Insights

7. Benign Prostatic Hyperplasia Discovery Stage Pipeline Insights

8. Benign Prostatic Hyperplasia Drug Development Activities - Geographic Landscape

8.1. Benign Prostatic Hyperplasia R&D Activities in North America

8.2. Benign Prostatic Hyperplasia R&D Activities in Europe

9. Benign Prostatic Hyperplasia Pipeline - Licensing Activities

Tables & Figures

For more information visit http://www.researchandmarkets.com/research/gp6tkz/global_benign

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals




View Comments and Join the Discussion!